

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 6.14197877 |
| 2 | nuclear pore organization (GO:0006999) | 5.13977827 |
| 3 | alpha-linolenic acid metabolic process (GO:0036109) | 4.70569869 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 4.60173535 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.60173535 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.40815527 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 4.40815527 |
| 8 | pore complex assembly (GO:0046931) | 4.36922297 |
| 9 | regulation of NFAT protein import into nucleus (GO:0051532) | 4.33098489 |
| 10 | cysteine metabolic process (GO:0006534) | 4.30850750 |
| 11 | regulation of RNA export from nucleus (GO:0046831) | 4.14319997 |
| 12 | lysine catabolic process (GO:0006554) | 4.06188666 |
| 13 | lysine metabolic process (GO:0006553) | 4.06188666 |
| 14 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.94407631 |
| 15 | mitotic chromosome condensation (GO:0007076) | 3.94195538 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 3.84748769 |
| 17 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.78913021 |
| 18 | regulation of cholesterol homeostasis (GO:2000188) | 3.76934671 |
| 19 | urea metabolic process (GO:0019627) | 3.70552197 |
| 20 | urea cycle (GO:0000050) | 3.70552197 |
| 21 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.70035408 |
| 22 | DNA unwinding involved in DNA replication (GO:0006268) | 3.68207124 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 3.62956340 |
| 24 | embryonic process involved in female pregnancy (GO:0060136) | 3.62433563 |
| 25 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.62341642 |
| 26 | glutamate metabolic process (GO:0006536) | 3.61123430 |
| 27 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.57692163 |
| 28 | regulation of translational termination (GO:0006449) | 3.52580374 |
| 29 | aromatic amino acid family catabolic process (GO:0009074) | 3.52566304 |
| 30 | cell-substrate adherens junction assembly (GO:0007045) | 3.45395938 |
| 31 | focal adhesion assembly (GO:0048041) | 3.45395938 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 3.44689967 |
| 33 | adherens junction assembly (GO:0034333) | 3.44499347 |
| 34 | protein retention in ER lumen (GO:0006621) | 3.43061775 |
| 35 | vesicle coating (GO:0006901) | 3.42407125 |
| 36 | glyoxylate metabolic process (GO:0046487) | 3.38876418 |
| 37 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.38553169 |
| 38 | bile acid biosynthetic process (GO:0006699) | 3.37509197 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 3.29621493 |
| 40 | kynurenine metabolic process (GO:0070189) | 3.29360420 |
| 41 | low-density lipoprotein particle clearance (GO:0034383) | 3.27905398 |
| 42 | layer formation in cerebral cortex (GO:0021819) | 3.27618484 |
| 43 | negative regulation of cholesterol transport (GO:0032375) | 3.25602553 |
| 44 | negative regulation of sterol transport (GO:0032372) | 3.25602553 |
| 45 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.25182584 |
| 46 | acetyl-CoA metabolic process (GO:0006084) | 3.24803477 |
| 47 | cell-substrate junction assembly (GO:0007044) | 3.23525152 |
| 48 | complement activation, alternative pathway (GO:0006957) | 3.23394139 |
| 49 | RNA stabilization (GO:0043489) | 3.21652099 |
| 50 | mRNA stabilization (GO:0048255) | 3.21652099 |
| 51 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 3.20873502 |
| 52 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 3.20873502 |
| 53 | aspartate family amino acid catabolic process (GO:0009068) | 3.19516866 |
| 54 | synaptic vesicle maturation (GO:0016188) | 3.16286901 |
| 55 | activation of Rac GTPase activity (GO:0032863) | 3.14806646 |
| 56 | glycine metabolic process (GO:0006544) | 3.13823518 |
| 57 | serine family amino acid metabolic process (GO:0009069) | 3.13678367 |
| 58 | cellular protein complex localization (GO:0034629) | 3.13644125 |
| 59 | mitotic sister chromatid cohesion (GO:0007064) | 3.13432924 |
| 60 | protein localization to endosome (GO:0036010) | 3.13213730 |
| 61 | cellular modified amino acid catabolic process (GO:0042219) | 3.13112285 |
| 62 | dosage compensation (GO:0007549) | 3.12026230 |
| 63 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.11695162 |
| 64 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.11545208 |
| 65 | protein localization to microtubule (GO:0035372) | 3.08198513 |
| 66 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.07932194 |
| 67 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 3.07662021 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 3.07230950 |
| 69 | acylglycerol catabolic process (GO:0046464) | 3.06496847 |
| 70 | neutral lipid catabolic process (GO:0046461) | 3.06496847 |
| 71 | regulation of protein activation cascade (GO:2000257) | 3.05564907 |
| 72 | 2-oxoglutarate metabolic process (GO:0006103) | 3.04998602 |
| 73 | plasma lipoprotein particle clearance (GO:0034381) | 3.03453851 |
| 74 | homocysteine metabolic process (GO:0050667) | 3.01606864 |
| 75 | serine family amino acid biosynthetic process (GO:0009070) | 2.99784224 |
| 76 | peptidyl-lysine dimethylation (GO:0018027) | 2.99631318 |
| 77 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.98425596 |
| 78 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.97781371 |
| 79 | paraxial mesoderm development (GO:0048339) | 2.96190461 |
| 80 | protein export from nucleus (GO:0006611) | 2.95809642 |
| 81 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.95417772 |
| 82 | high-density lipoprotein particle remodeling (GO:0034375) | 2.93985273 |
| 83 | regulation of fibrinolysis (GO:0051917) | 2.92911054 |
| 84 | hemidesmosome assembly (GO:0031581) | 2.92239653 |
| 85 | regulation of histone H3-K27 methylation (GO:0061085) | 2.91249182 |
| 86 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.90544147 |
| 87 | histone H3-K9 demethylation (GO:0033169) | 2.90199317 |
| 88 | protein carboxylation (GO:0018214) | 2.89805039 |
| 89 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.89805039 |
| 90 | regulation of complement activation (GO:0030449) | 2.88639142 |
| 91 | triglyceride catabolic process (GO:0019433) | 2.87316362 |
| 92 | Golgi transport vesicle coating (GO:0048200) | 2.87161942 |
| 93 | COPI coating of Golgi vesicle (GO:0048205) | 2.87161942 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 2.87055551 |
| 95 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.86955539 |
| 96 | acyl-CoA biosynthetic process (GO:0071616) | 2.85950088 |
| 97 | thioester biosynthetic process (GO:0035384) | 2.85950088 |
| 98 | bile acid metabolic process (GO:0008206) | 2.84024420 |
| 99 | peptidyl-threonine modification (GO:0018210) | 2.83086183 |
| 100 | alpha-amino acid catabolic process (GO:1901606) | 2.82959964 |
| 101 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.81491058 |
| 102 | ethanol oxidation (GO:0006069) | 2.80900044 |
| 103 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.80592932 |
| 104 | locomotory exploration behavior (GO:0035641) | 2.80291207 |
| 105 | amino-acid betaine metabolic process (GO:0006577) | 2.79327111 |
| 106 | fatty acid homeostasis (GO:0055089) | 2.78040278 |
| 107 | cellular amino acid catabolic process (GO:0009063) | 2.77907469 |
| 108 | regulation of triglyceride catabolic process (GO:0010896) | 2.75360384 |
| 109 | regulation of ARF protein signal transduction (GO:0032012) | 2.75326969 |
| 110 | COPII vesicle coating (GO:0048208) | 2.74640017 |
| 111 | acylglycerol homeostasis (GO:0055090) | 2.73497325 |
| 112 | triglyceride homeostasis (GO:0070328) | 2.73497325 |
| 113 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.73418933 |
| 114 | histone H3-K36 demethylation (GO:0070544) | 2.72585152 |
| 115 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.71515985 |
| 116 | corticosteroid receptor signaling pathway (GO:0031958) | 2.71440459 |
| 117 | peptidyl-threonine phosphorylation (GO:0018107) | 2.71154027 |
| 118 | drug catabolic process (GO:0042737) | 2.71079754 |
| 119 | hypotonic response (GO:0006971) | 2.70113779 |
| 120 | protein localization to chromosome, centromeric region (GO:0071459) | 2.69433911 |
| 121 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.69271643 |
| 122 | histone lysine demethylation (GO:0070076) | 2.68877246 |
| 123 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.66607503 |
| 124 | protein complex localization (GO:0031503) | 2.66550211 |
| 125 | skin morphogenesis (GO:0043589) | 2.65560599 |
| 126 | cell adhesion mediated by integrin (GO:0033627) | 2.65362773 |
| 127 | cortical actin cytoskeleton organization (GO:0030866) | 2.64789337 |
| 128 | stress granule assembly (GO:0034063) | 2.64404753 |
| 129 | dicarboxylic acid catabolic process (GO:0043649) | 2.64151614 |
| 130 | sodium ion export (GO:0071436) | 2.63813059 |
| 131 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.63652278 |
| 132 | nucleobase catabolic process (GO:0046113) | 2.63531390 |
| 133 | negative regulation of lipid transport (GO:0032369) | 2.62586139 |
| 134 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.61943889 |
| 135 | regulation of mitotic spindle organization (GO:0060236) | 2.61834795 |
| 136 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.61638453 |
| 137 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.61285550 |
| 138 | ketone body metabolic process (GO:1902224) | 2.60317214 |
| 139 | reverse cholesterol transport (GO:0043691) | 2.59967948 |
| 140 | one-carbon metabolic process (GO:0006730) | 2.58651322 |
| 141 | triglyceride metabolic process (GO:0006641) | 2.57270747 |
| 142 | tryptophan catabolic process (GO:0006569) | 2.57237132 |
| 143 | indole-containing compound catabolic process (GO:0042436) | 2.57237132 |
| 144 | indolalkylamine catabolic process (GO:0046218) | 2.57237132 |
| 145 | histone demethylation (GO:0016577) | 2.57058142 |
| 146 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.56057727 |
| 147 | stress fiber assembly (GO:0043149) | 2.54957407 |
| 148 | negative regulation of cell size (GO:0045792) | 2.54904674 |
| 149 | clathrin coat assembly (GO:0048268) | 2.53837663 |
| 150 | acylglycerol metabolic process (GO:0006639) | 2.53740827 |
| 151 | short-chain fatty acid metabolic process (GO:0046459) | 2.53463078 |
| 152 | pre-miRNA processing (GO:0031054) | 2.52324589 |
| 153 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.51746588 |
| 154 | tricarboxylic acid metabolic process (GO:0072350) | 2.51194312 |
| 155 | regulation of early endosome to late endosome transport (GO:2000641) | 2.50641252 |
| 156 | neutral lipid metabolic process (GO:0006638) | 2.50475355 |
| 157 | cellular glucuronidation (GO:0052695) | 2.50445852 |
| 158 | fatty acid transmembrane transport (GO:1902001) | 2.49639967 |
| 159 | glutamate secretion (GO:0014047) | 2.48820356 |
| 160 | positive regulation of fatty acid oxidation (GO:0046321) | 2.48257662 |
| 161 | triglyceride biosynthetic process (GO:0019432) | 2.48193599 |
| 162 | positive regulation of protein export from nucleus (GO:0046827) | 2.47482590 |
| 163 | localization within membrane (GO:0051668) | 2.47422433 |
| 164 | positive regulation of nuclease activity (GO:0032075) | 2.46409922 |
| 165 | regulation of translational fidelity (GO:0006450) | 2.46337611 |
| 166 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.46047975 |
| 167 | heterochromatin organization (GO:0070828) | 2.43649191 |
| 168 | ER-nucleus signaling pathway (GO:0006984) | 2.43454896 |
| 169 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.43095641 |
| 170 | NLS-bearing protein import into nucleus (GO:0006607) | 2.42564174 |
| 171 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.41198974 |
| 172 | response to laminar fluid shear stress (GO:0034616) | 2.38991707 |
| 173 | negative regulation of fatty acid transport (GO:2000192) | 2.38491079 |
| 174 | receptor recycling (GO:0001881) | 2.37151821 |
| 175 | protein targeting to plasma membrane (GO:0072661) | 2.34639101 |
| 176 | regulation of sister chromatid cohesion (GO:0007063) | 2.34346039 |
| 177 | negative regulation of histone methylation (GO:0031061) | 2.32973825 |
| 178 | desmosome organization (GO:0002934) | 2.29708603 |
| 179 | epithelial cell-cell adhesion (GO:0090136) | 2.28964220 |
| 180 | mating behavior (GO:0007617) | 2.27124966 |
| 181 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.26466016 |
| 182 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.25926483 |
| 183 | negative regulation of anoikis (GO:2000811) | 2.24022159 |
| 184 | cellular response to unfolded protein (GO:0034620) | 2.23377259 |
| 185 | histone H2B ubiquitination (GO:0033523) | 2.23252510 |
| 186 | protein demethylation (GO:0006482) | 2.22676073 |
| 187 | protein dealkylation (GO:0008214) | 2.22676073 |
| 188 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.21460140 |
| 189 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.20712869 |
| 190 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.20422918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.20476358 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.33371873 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.30397623 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.03056262 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.95394480 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.57674238 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.42048630 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.16921774 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.96518812 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.39249738 |
| 11 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.29956043 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.28828451 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19863695 |
| 14 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.03026619 |
| 15 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.00490948 |
| 16 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.99279517 |
| 17 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.91190191 |
| 18 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.89530482 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.88803058 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.83483718 |
| 21 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.82766086 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.78483811 |
| 23 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.76343665 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.70296402 |
| 25 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.65842654 |
| 26 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.65781160 |
| 27 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.65548893 |
| 28 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.64506235 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 1.63653689 |
| 30 | KDM2B_26808549_Chip-Seq_K562_Human | 1.63335509 |
| 31 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.62909172 |
| 32 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61706478 |
| 33 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.61670322 |
| 34 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.61639787 |
| 35 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.61391302 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.59885842 |
| 37 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56508133 |
| 38 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.55353621 |
| 39 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.54872356 |
| 40 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.53834557 |
| 41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53630168 |
| 42 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.52822684 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.51635818 |
| 44 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.51566303 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.50184919 |
| 46 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.48296681 |
| 47 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.46851617 |
| 48 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.45939426 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.42768673 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42557089 |
| 51 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.42125415 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40806333 |
| 53 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40585753 |
| 54 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.40176403 |
| 55 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.39652438 |
| 56 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.39299890 |
| 57 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.37402546 |
| 58 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.36574790 |
| 59 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.35740355 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34427016 |
| 61 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.34081557 |
| 62 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.33856370 |
| 63 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.32233842 |
| 64 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.31206053 |
| 65 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.30842441 |
| 66 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.30842441 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30804299 |
| 68 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.30481933 |
| 69 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.30419778 |
| 70 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.30045472 |
| 71 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.28840832 |
| 72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28045736 |
| 73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27781364 |
| 74 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.27778019 |
| 75 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.27224385 |
| 76 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.27219916 |
| 77 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.27140010 |
| 78 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.26104842 |
| 79 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25305234 |
| 80 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.24376735 |
| 81 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23738438 |
| 82 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.23415019 |
| 83 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.22562085 |
| 84 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.19834813 |
| 85 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18780946 |
| 86 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.17650100 |
| 87 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17360218 |
| 88 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.17246054 |
| 89 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.16743144 |
| 90 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.15675847 |
| 91 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.15538828 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13881760 |
| 93 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.13494734 |
| 94 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13305793 |
| 95 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.13047306 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13022138 |
| 97 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.12396022 |
| 98 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12248894 |
| 99 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.11975215 |
| 100 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.11116664 |
| 101 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.10785244 |
| 102 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10745528 |
| 103 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.10480262 |
| 104 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10321081 |
| 105 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10055589 |
| 106 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.10033228 |
| 107 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09576495 |
| 108 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.08054771 |
| 109 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.07370607 |
| 110 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.06791349 |
| 111 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.05458667 |
| 112 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.04907918 |
| 113 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04746399 |
| 114 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03877503 |
| 115 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.03375617 |
| 116 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02602978 |
| 117 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.02461579 |
| 118 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01436351 |
| 119 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01406120 |
| 120 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.00585507 |
| 121 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99465813 |
| 122 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.98439205 |
| 123 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97994734 |
| 124 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97241604 |
| 125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97169280 |
| 126 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92865268 |
| 127 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90331099 |
| 128 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90331099 |
| 129 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90222743 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88863211 |
| 131 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88110128 |
| 132 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87280443 |
| 133 | P68_20966046_ChIP-Seq_HELA_Human | 0.86831915 |
| 134 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.86636068 |
| 135 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86513309 |
| 136 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.84739822 |
| 137 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.84144303 |
| 138 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.82428301 |
| 139 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.81467463 |
| 140 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.79349957 |
| 141 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.79077213 |
| 142 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.78886865 |
| 143 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.78285815 |
| 144 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77439970 |
| 145 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77359073 |
| 146 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.76140604 |
| 147 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.75903118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.99820667 |
| 2 | MP0005360_urolithiasis | 4.84148518 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 4.51249553 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.96754219 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.65991174 |
| 6 | MP0005365_abnormal_bile_salt | 3.54611713 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 2.80027161 |
| 8 | MP0002009_preneoplasia | 2.71068797 |
| 9 | MP0003329_amyloid_beta_deposits | 2.63514367 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.62802133 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.62664092 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.60641199 |
| 13 | MP0005409_darkened_coat_color | 2.55435846 |
| 14 | MP0005083_abnormal_biliary_tract | 2.35109945 |
| 15 | MP0003252_abnormal_bile_duct | 2.30991312 |
| 16 | MP0009840_abnormal_foam_cell | 2.28373750 |
| 17 | MP0004185_abnormal_adipocyte_glucose | 2.00789533 |
| 18 | MP0000604_amyloidosis | 1.92134596 |
| 19 | MP0001666_abnormal_nutrient_absorption | 1.91899992 |
| 20 | MP0010352_gastrointestinal_tract_polyps | 1.91498622 |
| 21 | MP0008057_abnormal_DNA_replication | 1.83717389 |
| 22 | MP0005332_abnormal_amino_acid | 1.79523426 |
| 23 | MP0008260_abnormal_autophagy | 1.78243801 |
| 24 | MP0004270_analgesia | 1.73415541 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.71178940 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.67328407 |
| 27 | MP0004130_abnormal_muscle_cell | 1.66127295 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.64226908 |
| 29 | MP0000537_abnormal_urethra_morphology | 1.61178782 |
| 30 | MP0004957_abnormal_blastocyst_morpholog | 1.60592290 |
| 31 | MP0003111_abnormal_nucleus_morphology | 1.58424551 |
| 32 | MP0005076_abnormal_cell_differentiation | 1.55872869 |
| 33 | MP0000609_abnormal_liver_physiology | 1.55571671 |
| 34 | MP0002796_impaired_skin_barrier | 1.53535559 |
| 35 | MP0000350_abnormal_cell_proliferation | 1.53243157 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.49198788 |
| 37 | MP0000733_abnormal_muscle_development | 1.48389648 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.46875638 |
| 39 | MP0005257_abnormal_intraocular_pressure | 1.44432832 |
| 40 | MP0004858_abnormal_nervous_system | 1.43753577 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.43533265 |
| 42 | MP0009053_abnormal_anal_canal | 1.40192211 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.39488888 |
| 44 | MP0001849_ear_inflammation | 1.37578682 |
| 45 | MP0001915_intracranial_hemorrhage | 1.36677443 |
| 46 | MP0005380_embryogenesis_phenotype | 1.36671642 |
| 47 | MP0001672_abnormal_embryogenesis/_devel | 1.36671642 |
| 48 | MP0008961_abnormal_basal_metabolism | 1.36426798 |
| 49 | MP0002060_abnormal_skin_morphology | 1.34145162 |
| 50 | MP0005621_abnormal_cell_physiology | 1.33603663 |
| 51 | MP0003984_embryonic_growth_retardation | 1.30979028 |
| 52 | MP0004885_abnormal_endolymph | 1.30929719 |
| 53 | MP0003077_abnormal_cell_cycle | 1.27917083 |
| 54 | MP0003941_abnormal_skin_development | 1.26785540 |
| 55 | MP0002086_abnormal_extraembryonic_tissu | 1.26199320 |
| 56 | MP0003300_gastrointestinal_ulcer | 1.25903938 |
| 57 | MP0005375_adipose_tissue_phenotype | 1.24445581 |
| 58 | MP0003635_abnormal_synaptic_transmissio | 1.24224938 |
| 59 | MP0002088_abnormal_embryonic_growth/wei | 1.23017821 |
| 60 | MP0002080_prenatal_lethality | 1.19679574 |
| 61 | MP0003195_calcinosis | 1.14387186 |
| 62 | MP0000003_abnormal_adipose_tissue | 1.13982002 |
| 63 | MP0008932_abnormal_embryonic_tissue | 1.13660019 |
| 64 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.12906575 |
| 65 | MP0003115_abnormal_respiratory_system | 1.10249159 |
| 66 | MP0005187_abnormal_penis_morphology | 1.09415055 |
| 67 | MP0004087_abnormal_muscle_fiber | 1.08003902 |
| 68 | MP0000579_abnormal_nail_morphology | 1.07736268 |
| 69 | MP0004264_abnormal_extraembryonic_tissu | 1.07563887 |
| 70 | MP0010630_abnormal_cardiac_muscle | 1.06165086 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 1.06021827 |
| 72 | MP0000013_abnormal_adipose_tissue | 1.05467925 |
| 73 | MP0001697_abnormal_embryo_size | 1.05383740 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 1.04268556 |
| 75 | MP0009672_abnormal_birth_weight | 1.04212410 |
| 76 | MP0004272_abnormal_basement_membrane | 1.04111229 |
| 77 | MP0003690_abnormal_glial_cell | 1.03872627 |
| 78 | MP0002089_abnormal_postnatal_growth/wei | 1.03662119 |
| 79 | MP0000759_abnormal_skeletal_muscle | 1.03071944 |
| 80 | MP0000428_abnormal_craniofacial_morphol | 1.02043624 |
| 81 | MP0005058_abnormal_lysosome_morphology | 1.01953133 |
| 82 | MP0004233_abnormal_muscle_weight | 1.00857070 |
| 83 | MP0005384_cellular_phenotype | 1.00836993 |
| 84 | MP0003868_abnormal_feces_composition | 1.00780780 |
| 85 | MP0001730_embryonic_growth_arrest | 0.99666609 |
| 86 | MP0001216_abnormal_epidermal_layer | 0.99659999 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 0.99154664 |
| 88 | MP0002877_abnormal_melanocyte_morpholog | 0.98114899 |
| 89 | MP0003283_abnormal_digestive_organ | 0.95909709 |
| 90 | MP0003828_pulmonary_edema | 0.95375855 |
| 91 | MP0010307_abnormal_tumor_latency | 0.94855785 |
| 92 | MP0000751_myopathy | 0.94799490 |
| 93 | MP0003632_abnormal_nervous_system | 0.94189345 |
| 94 | MP0002085_abnormal_embryonic_tissue | 0.93398295 |
| 95 | MP0000747_muscle_weakness | 0.92990519 |
| 96 | MP0003123_paternal_imprinting | 0.91173005 |
| 97 | MP0002063_abnormal_learning/memory/cond | 0.90951306 |
| 98 | MP0009703_decreased_birth_body | 0.90700123 |
| 99 | MP0004947_skin_inflammation | 0.90126806 |
| 100 | MP0010678_abnormal_skin_adnexa | 0.89826597 |
| 101 | MP0002896_abnormal_bone_mineralization | 0.89720539 |
| 102 | MP0004019_abnormal_vitamin_homeostasis | 0.89017440 |
| 103 | MP0000377_abnormal_hair_follicle | 0.88334151 |
| 104 | MP0009643_abnormal_urine_homeostasis | 0.87808691 |
| 105 | MP0002971_abnormal_brown_adipose | 0.87669440 |
| 106 | MP0001851_eye_inflammation | 0.87548796 |
| 107 | MP0003950_abnormal_plasma_membrane | 0.87409865 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.86415805 |
| 109 | MP0002092_abnormal_eye_morphology | 0.85719142 |
| 110 | MP0003385_abnormal_body_wall | 0.85335086 |
| 111 | MP0003693_abnormal_embryo_hatching | 0.84383348 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 0.84037465 |
| 113 | MP0004811_abnormal_neuron_physiology | 0.81441081 |
| 114 | MP0000762_abnormal_tongue_morphology | 0.80995998 |
| 115 | MP0003634_abnormal_glial_cell | 0.80773149 |
| 116 | MP0005451_abnormal_body_composition | 0.80583094 |
| 117 | MP0002254_reproductive_system_inflammat | 0.80528710 |
| 118 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79126685 |
| 119 | MP0004043_abnormal_pH_regulation | 0.78135503 |
| 120 | MP0002697_abnormal_eye_size | 0.77935163 |
| 121 | MP0004197_abnormal_fetal_growth/weight/ | 0.77591209 |
| 122 | MP0003453_abnormal_keratinocyte_physiol | 0.77385209 |
| 123 | MP0005501_abnormal_skin_physiology | 0.77168505 |
| 124 | MP0005670_abnormal_white_adipose | 0.77126271 |
| 125 | MP0002138_abnormal_hepatobiliary_system | 0.76771644 |
| 126 | MP0005623_abnormal_meninges_morphology | 0.75658307 |
| 127 | MP0001340_abnormal_eyelid_morphology | 0.75537689 |
| 128 | MP0000858_altered_metastatic_potential | 0.75268223 |
| 129 | MP0001756_abnormal_urination | 0.75262114 |
| 130 | MP0000598_abnormal_liver_morphology | 0.74871911 |
| 131 | MP0003075_altered_response_to | 0.74864511 |
| 132 | MP0001348_abnormal_lacrimal_gland | 0.74593590 |
| 133 | MP0006138_congestive_heart_failure | 0.74500608 |
| 134 | MP0003303_peritoneal_inflammation | 0.74484180 |
| 135 | MP0001299_abnormal_eye_distance/ | 0.73387879 |
| 136 | MP0005535_abnormal_body_temperature | 0.73011878 |
| 137 | MP0000955_abnormal_spinal_cord | 0.68600923 |
| 138 | MP0002084_abnormal_developmental_patter | 0.66179597 |
| 139 | MP0003119_abnormal_digestive_system | 0.66016776 |
| 140 | MP0002733_abnormal_thermal_nociception | 0.65906858 |
| 141 | MP0001881_abnormal_mammary_gland | 0.65266907 |
| 142 | MP0001177_atelectasis | 0.64229315 |
| 143 | MP0002269_muscular_atrophy | 0.62540075 |
| 144 | MP0005334_abnormal_fat_pad | 0.61987436 |
| 145 | MP0005448_abnormal_energy_balance | 0.61554930 |
| 146 | MP0002822_catalepsy | 0.61407841 |
| 147 | MP0005248_abnormal_Harderian_gland | 0.61145149 |
| 148 | MP0002064_seizures | 0.60798317 |
| 149 | MP0008770_decreased_survivor_rate | 0.60446273 |
| 150 | MP0003631_nervous_system_phenotype | 0.60433316 |
| 151 | MP0005023_abnormal_wound_healing | 0.60326061 |
| 152 | MP0001440_abnormal_grooming_behavior | 0.59705606 |
| 153 | MP0003091_abnormal_cell_migration | 0.58887951 |
| 154 | MP0005275_abnormal_skin_tensile | 0.58009697 |
| 155 | MP0002653_abnormal_ependyma_morphology | 0.58000635 |
| 156 | MP0003890_abnormal_embryonic-extraembry | 0.57812698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.72751867 |
| 2 | Xanthomatosis (HP:0000991) | 3.74801120 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 3.57686088 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.45539716 |
| 5 | Insidious onset (HP:0003587) | 3.43430574 |
| 6 | Termporal pattern (HP:0011008) | 3.43430574 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.35329378 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 3.32240619 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 3.29250268 |
| 10 | Abnormality of the lower motor neuron (HP:0002366) | 3.25057045 |
| 11 | Complement deficiency (HP:0004431) | 3.08127499 |
| 12 | Abnormality of the Achilles tendon (HP:0005109) | 3.05403033 |
| 13 | Spastic diplegia (HP:0001264) | 3.02686666 |
| 14 | Distal lower limb amyotrophy (HP:0008944) | 3.02615521 |
| 15 | Epidermoid cyst (HP:0200040) | 2.82772226 |
| 16 | Achilles tendon contracture (HP:0001771) | 2.77091742 |
| 17 | Gout (HP:0001997) | 2.76605642 |
| 18 | Hyperglycinemia (HP:0002154) | 2.74996814 |
| 19 | Lower limb amyotrophy (HP:0007210) | 2.73666128 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 2.73336778 |
| 21 | Hyperammonemia (HP:0001987) | 2.65047694 |
| 22 | Ketosis (HP:0001946) | 2.64426116 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 2.60565545 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.60565545 |
| 25 | Back pain (HP:0003418) | 2.53556571 |
| 26 | Heterotopia (HP:0002282) | 2.52128094 |
| 27 | Abnormality of oral frenula (HP:0000190) | 2.51970867 |
| 28 | Neurofibrillary tangles (HP:0002185) | 2.49740899 |
| 29 | Hypolipoproteinemia (HP:0010981) | 2.47960208 |
| 30 | Long palpebral fissure (HP:0000637) | 2.45253990 |
| 31 | Hyperglycinuria (HP:0003108) | 2.44216207 |
| 32 | Premature rupture of membranes (HP:0001788) | 2.43149500 |
| 33 | Vertebral arch anomaly (HP:0008438) | 2.41629561 |
| 34 | Supranuclear gaze palsy (HP:0000605) | 2.41494484 |
| 35 | Global brain atrophy (HP:0002283) | 2.41060377 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.38800780 |
| 37 | Protrusio acetabuli (HP:0003179) | 2.34602986 |
| 38 | Distal upper limb amyotrophy (HP:0007149) | 2.34200845 |
| 39 | Upper limb amyotrophy (HP:0009129) | 2.34200845 |
| 40 | Asymmetry of the thorax (HP:0001555) | 2.32883418 |
| 41 | Resting tremor (HP:0002322) | 2.32456433 |
| 42 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.30866003 |
| 43 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.30667475 |
| 44 | Papillary thyroid carcinoma (HP:0002895) | 2.30288765 |
| 45 | Hand muscle atrophy (HP:0009130) | 2.29403972 |
| 46 | Relative macrocephaly (HP:0004482) | 2.26998675 |
| 47 | Spinal cord lesions (HP:0100561) | 2.25815003 |
| 48 | Syringomyelia (HP:0003396) | 2.25815003 |
| 49 | Abnormality of the common coagulation pathway (HP:0010990) | 2.23090881 |
| 50 | Abnormality of complement system (HP:0005339) | 2.22431449 |
| 51 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.21230565 |
| 52 | Urinary urgency (HP:0000012) | 2.21177639 |
| 53 | Ketoacidosis (HP:0001993) | 2.17168753 |
| 54 | Turricephaly (HP:0000262) | 2.13230073 |
| 55 | Hypoalphalipoproteinemia (HP:0003233) | 2.12531167 |
| 56 | Flat acetabular roof (HP:0003180) | 2.12247275 |
| 57 | Abnormality of the corticospinal tract (HP:0002492) | 2.11831701 |
| 58 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.11490609 |
| 59 | Osteolytic defects of the hand bones (HP:0009699) | 2.11490609 |
| 60 | Amyotrophic lateral sclerosis (HP:0007354) | 2.11064087 |
| 61 | Action tremor (HP:0002345) | 2.09284149 |
| 62 | Cortical dysplasia (HP:0002539) | 2.09131153 |
| 63 | Neonatal onset (HP:0003623) | 2.09097597 |
| 64 | Malnutrition (HP:0004395) | 2.08362379 |
| 65 | Deep palmar crease (HP:0006191) | 2.07756900 |
| 66 | Intention tremor (HP:0002080) | 2.07317334 |
| 67 | Dysmetric saccades (HP:0000641) | 2.05586729 |
| 68 | Broad face (HP:0000283) | 2.04499500 |
| 69 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.04421736 |
| 70 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.03963458 |
| 71 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.02872776 |
| 72 | Increased connective tissue (HP:0009025) | 2.02577785 |
| 73 | Cholecystitis (HP:0001082) | 2.01783635 |
| 74 | Abnormal gallbladder physiology (HP:0012438) | 2.01783635 |
| 75 | Deep philtrum (HP:0002002) | 2.01518918 |
| 76 | Vertebral compression fractures (HP:0002953) | 1.99697903 |
| 77 | Visual hallucinations (HP:0002367) | 1.98736681 |
| 78 | Myokymia (HP:0002411) | 1.97961778 |
| 79 | Pseudobulbar signs (HP:0002200) | 1.97902711 |
| 80 | Insomnia (HP:0100785) | 1.95808108 |
| 81 | Hypoglycemic coma (HP:0001325) | 1.95770145 |
| 82 | Deviation of the thumb (HP:0009603) | 1.95690960 |
| 83 | Impaired social interactions (HP:0000735) | 1.94303736 |
| 84 | Abnormal social behavior (HP:0012433) | 1.94303736 |
| 85 | Spastic tetraparesis (HP:0001285) | 1.92564541 |
| 86 | Tetraplegia (HP:0002445) | 1.90128726 |
| 87 | Enlarged penis (HP:0000040) | 1.89059473 |
| 88 | Fat malabsorption (HP:0002630) | 1.88829928 |
| 89 | Hammertoe (HP:0001765) | 1.88808763 |
| 90 | Macroorchidism (HP:0000053) | 1.87366666 |
| 91 | Spinal rigidity (HP:0003306) | 1.87349986 |
| 92 | Decreased motor nerve conduction velocity (HP:0003431) | 1.86982170 |
| 93 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.86889714 |
| 94 | Spastic gait (HP:0002064) | 1.86112870 |
| 95 | Leiomyosarcoma (HP:0100243) | 1.86069744 |
| 96 | Uterine leiomyosarcoma (HP:0002891) | 1.86069744 |
| 97 | Hepatocellular carcinoma (HP:0001402) | 1.85107103 |
| 98 | Sensorimotor neuropathy (HP:0007141) | 1.85092264 |
| 99 | Pointed chin (HP:0000307) | 1.84185311 |
| 100 | Abnormality of purine metabolism (HP:0004352) | 1.83931384 |
| 101 | Neonatal hypoglycemia (HP:0001998) | 1.82408173 |
| 102 | Skin nodule (HP:0200036) | 1.81844050 |
| 103 | Cubitus valgus (HP:0002967) | 1.81462295 |
| 104 | Status epilepticus (HP:0002133) | 1.80453345 |
| 105 | Wormian bones (HP:0002645) | 1.79607500 |
| 106 | Pelvic girdle muscle weakness (HP:0003749) | 1.79297090 |
| 107 | Hyperacusis (HP:0010780) | 1.79223080 |
| 108 | Disproportionate tall stature (HP:0001519) | 1.78522173 |
| 109 | Scanning speech (HP:0002168) | 1.77642372 |
| 110 | Arnold-Chiari malformation (HP:0002308) | 1.76156842 |
| 111 | Ankyloglossia (HP:0010296) | 1.76104875 |
| 112 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.74701751 |
| 113 | Increased nuchal translucency (HP:0010880) | 1.74514188 |
| 114 | Distal sensory impairment (HP:0002936) | 1.74449551 |
| 115 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.74408976 |
| 116 | Abnormal cartilage morphology (HP:0002763) | 1.73681986 |
| 117 | Sparse lateral eyebrow (HP:0005338) | 1.73571659 |
| 118 | Progressive external ophthalmoplegia (HP:0000590) | 1.73209046 |
| 119 | Short nail (HP:0001799) | 1.72751275 |
| 120 | Postural instability (HP:0002172) | 1.72667531 |
| 121 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.72207981 |
| 122 | Proximal placement of thumb (HP:0009623) | 1.72202879 |
| 123 | Glomerulosclerosis (HP:0000096) | 1.71586767 |
| 124 | Mitral regurgitation (HP:0001653) | 1.70988181 |
| 125 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.70743295 |
| 126 | Tetraparesis (HP:0002273) | 1.70545034 |
| 127 | Clonus (HP:0002169) | 1.70095242 |
| 128 | Arterial tortuosity (HP:0005116) | 1.69769781 |
| 129 | Astrocytoma (HP:0009592) | 1.69638229 |
| 130 | Abnormality of the astrocytes (HP:0100707) | 1.69638229 |
| 131 | Overriding aorta (HP:0002623) | 1.68952701 |
| 132 | Torticollis (HP:0000473) | 1.68623090 |
| 133 | Cholelithiasis (HP:0001081) | 1.68428380 |
| 134 | Precocious puberty (HP:0000826) | 1.68091360 |
| 135 | Selective tooth agenesis (HP:0001592) | 1.68047769 |
| 136 | Increased variability in muscle fiber diameter (HP:0003557) | 1.67821776 |
| 137 | Atrophic scars (HP:0001075) | 1.67255654 |
| 138 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.66870847 |
| 139 | Ulnar bowing (HP:0003031) | 1.66658221 |
| 140 | Advanced eruption of teeth (HP:0006288) | 1.66643683 |
| 141 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.65606316 |
| 142 | Irritability (HP:0000737) | 1.65241349 |
| 143 | Elfin facies (HP:0004428) | 1.64739247 |
| 144 | Papilledema (HP:0001085) | 1.64580043 |
| 145 | Hypercholesterolemia (HP:0003124) | 1.64121190 |
| 146 | Overgrowth (HP:0001548) | 1.63923588 |
| 147 | Renal cell carcinoma (HP:0005584) | 1.63418848 |
| 148 | Neuronal loss in central nervous system (HP:0002529) | 1.63343049 |
| 149 | Ankle contracture (HP:0006466) | 1.63052127 |
| 150 | Abnormality of the intrinsic pathway (HP:0010989) | 1.62241980 |
| 151 | Delayed CNS myelination (HP:0002188) | 1.61637091 |
| 152 | Bronchomalacia (HP:0002780) | 1.61466395 |
| 153 | Cerebral aneurysm (HP:0004944) | 1.61318724 |
| 154 | Fibroma (HP:0010614) | 1.61220349 |
| 155 | Bladder carcinoma (HP:0002862) | 1.61089495 |
| 156 | Bladder neoplasm (HP:0009725) | 1.61089495 |
| 157 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.60952247 |
| 158 | Obstructive sleep apnea (HP:0002870) | 1.60219413 |
| 159 | Prolonged partial thromboplastin time (HP:0003645) | 1.60196510 |
| 160 | Shallow orbits (HP:0000586) | 1.60165556 |
| 161 | Abnormal gallbladder morphology (HP:0012437) | 1.60018566 |
| 162 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.59659219 |
| 163 | Intellectual disability, profound (HP:0002187) | 1.59217213 |
| 164 | Apathy (HP:0000741) | 1.58994581 |
| 165 | Ependymoma (HP:0002888) | 1.58189227 |
| 166 | Mitral valve prolapse (HP:0001634) | 1.58115864 |
| 167 | Abnormality of nucleobase metabolism (HP:0010932) | 1.57342149 |
| 168 | Hyperparathyroidism (HP:0000843) | 1.57260236 |
| 169 | Distal lower limb muscle weakness (HP:0009053) | 1.57176394 |
| 170 | Patellar dislocation (HP:0002999) | 1.57088042 |
| 171 | Lymphangioma (HP:0100764) | 1.56084354 |
| 172 | Depression (HP:0000716) | 1.55758577 |
| 173 | Subacute progressive viral hepatitis (HP:0006572) | 1.55568171 |
| 174 | Renal duplication (HP:0000075) | 1.55506540 |
| 175 | Germ cell neoplasia (HP:0100728) | 1.55495913 |
| 176 | Missing ribs (HP:0000921) | 1.55413789 |
| 177 | Shoulder girdle muscle weakness (HP:0003547) | 1.55015539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.69795208 |
| 2 | PRPF4B | 3.37944276 |
| 3 | MAP3K9 | 3.25255652 |
| 4 | PKN2 | 3.14080840 |
| 5 | KSR2 | 2.99194241 |
| 6 | LATS2 | 2.66440762 |
| 7 | EEF2K | 2.22683270 |
| 8 | SCYL2 | 2.20461518 |
| 9 | SMG1 | 2.08571892 |
| 10 | LATS1 | 2.07775752 |
| 11 | MAP3K2 | 2.05109675 |
| 12 | PAK6 | 2.03847922 |
| 13 | RIPK1 | 1.89294520 |
| 14 | ERN1 | 1.78454757 |
| 15 | BRD4 | 1.72743259 |
| 16 | KSR1 | 1.70870043 |
| 17 | SIK1 | 1.69225130 |
| 18 | MAP3K4 | 1.67113226 |
| 19 | RET | 1.61866274 |
| 20 | NEK1 | 1.61388411 |
| 21 | PRKD3 | 1.61027253 |
| 22 | MARK1 | 1.60247531 |
| 23 | MAP2K4 | 1.59639857 |
| 24 | MAP3K10 | 1.57624085 |
| 25 | NTRK1 | 1.56590911 |
| 26 | MAP3K13 | 1.50318188 |
| 27 | MAP3K6 | 1.49102485 |
| 28 | ALK | 1.46316392 |
| 29 | MINK1 | 1.43212813 |
| 30 | PTK6 | 1.38090559 |
| 31 | TAOK1 | 1.37838188 |
| 32 | BCKDK | 1.37068287 |
| 33 | ICK | 1.34952801 |
| 34 | TYRO3 | 1.31458110 |
| 35 | IRAK3 | 1.27912080 |
| 36 | NTRK3 | 1.25364243 |
| 37 | CAMKK1 | 1.25177829 |
| 38 | DAPK2 | 1.23820028 |
| 39 | ARAF | 1.23596235 |
| 40 | PDGFRA | 1.21708272 |
| 41 | MOS | 1.18485683 |
| 42 | BRAF | 1.17330313 |
| 43 | FGFR2 | 1.13280814 |
| 44 | PNCK | 1.13187697 |
| 45 | MAP3K14 | 1.12349909 |
| 46 | ERBB4 | 1.11700654 |
| 47 | PAK3 | 1.09196415 |
| 48 | FGFR4 | 1.09152386 |
| 49 | PDK4 | 1.06233926 |
| 50 | PDK3 | 1.06233926 |
| 51 | NEK9 | 1.02692025 |
| 52 | CAMK1G | 1.00670731 |
| 53 | STK38 | 1.00264571 |
| 54 | PTK2 | 0.97226891 |
| 55 | FER | 0.95319102 |
| 56 | BMX | 0.94614294 |
| 57 | LRRK2 | 0.89591859 |
| 58 | MET | 0.89246547 |
| 59 | MTOR | 0.89104311 |
| 60 | CAMK1D | 0.88214430 |
| 61 | CSNK1G2 | 0.87347199 |
| 62 | SIK3 | 0.85185000 |
| 63 | EPHA2 | 0.81460824 |
| 64 | MAP2K1 | 0.81248592 |
| 65 | MARK2 | 0.79602415 |
| 66 | AKT3 | 0.77947183 |
| 67 | TAOK2 | 0.77070493 |
| 68 | EPHA4 | 0.76127971 |
| 69 | PDPK1 | 0.72833011 |
| 70 | NEK6 | 0.72677292 |
| 71 | FGFR1 | 0.72019742 |
| 72 | MAP3K8 | 0.71216414 |
| 73 | TTK | 0.71135352 |
| 74 | EPHB1 | 0.69431357 |
| 75 | EIF2AK1 | 0.68602355 |
| 76 | PDK1 | 0.66712212 |
| 77 | WNK1 | 0.66503445 |
| 78 | CDK6 | 0.65990571 |
| 79 | PAK2 | 0.65735898 |
| 80 | CDK14 | 0.64429551 |
| 81 | LMTK2 | 0.64296891 |
| 82 | PRKCH | 0.64194992 |
| 83 | FGFR3 | 0.62770817 |
| 84 | STK11 | 0.62516832 |
| 85 | CDK5 | 0.62274533 |
| 86 | CDK4 | 0.62145895 |
| 87 | DYRK1B | 0.61973313 |
| 88 | TESK1 | 0.60696665 |
| 89 | RAF1 | 0.60307379 |
| 90 | CDK15 | 0.58955601 |
| 91 | FRK | 0.58258779 |
| 92 | MAPK10 | 0.58133508 |
| 93 | MAP3K1 | 0.57675473 |
| 94 | DMPK | 0.57405310 |
| 95 | PDGFRB | 0.55778846 |
| 96 | UHMK1 | 0.55522813 |
| 97 | CSNK1A1L | 0.55258804 |
| 98 | PBK | 0.54864115 |
| 99 | CSNK1G3 | 0.54111544 |
| 100 | YES1 | 0.52857241 |
| 101 | CDK18 | 0.52830036 |
| 102 | JAK2 | 0.52254288 |
| 103 | SGK494 | 0.51840186 |
| 104 | SGK223 | 0.51840186 |
| 105 | CSNK1E | 0.51755834 |
| 106 | PRKCZ | 0.51421791 |
| 107 | RPS6KA2 | 0.49643868 |
| 108 | CHEK1 | 0.49478744 |
| 109 | AKT2 | 0.49447837 |
| 110 | MAP2K3 | 0.49309279 |
| 111 | MST1R | 0.49079778 |
| 112 | NTRK2 | 0.48948774 |
| 113 | CSNK1G1 | 0.48826039 |
| 114 | BCR | 0.48122853 |
| 115 | CDK7 | 0.47896386 |
| 116 | SGK2 | 0.47839014 |
| 117 | SRPK1 | 0.47737996 |
| 118 | CDK11A | 0.47732667 |
| 119 | ERBB2 | 0.47286422 |
| 120 | LIMK1 | 0.46337612 |
| 121 | CDK12 | 0.45367886 |
| 122 | PRKAA1 | 0.43497772 |
| 123 | PDK2 | 0.43138914 |
| 124 | CSNK1D | 0.42887040 |
| 125 | SGK3 | 0.42526866 |
| 126 | GRK6 | 0.42196651 |
| 127 | BRSK1 | 0.41892003 |
| 128 | STK3 | 0.41461785 |
| 129 | TTN | 0.40945332 |
| 130 | SIK2 | 0.40293669 |
| 131 | TRPM7 | 0.38761949 |
| 132 | TESK2 | 0.38434224 |
| 133 | NEK2 | 0.37696463 |
| 134 | RPS6KA4 | 0.37244997 |
| 135 | MAP3K7 | 0.36422577 |
| 136 | PAK4 | 0.35613335 |
| 137 | MAPK11 | 0.35508504 |
| 138 | RPS6KB1 | 0.35175597 |
| 139 | ABL2 | 0.34864944 |
| 140 | RPS6KB2 | 0.34828025 |
| 141 | TSSK6 | 0.34772063 |
| 142 | STK10 | 0.34633893 |
| 143 | WNK4 | 0.34577574 |
| 144 | JAK1 | 0.33900878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.72894944 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.33606260 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.87090988 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79495509 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.41837032 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34809855 |
| 7 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.21537728 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.15744400 |
| 9 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.10228013 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07672837 |
| 11 | Thyroid cancer_Homo sapiens_hsa05216 | 2.04162914 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.02386904 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.01604713 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.84070970 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.83305814 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.80675551 |
| 17 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.80589856 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.80148524 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.68081638 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.62754149 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.60024077 |
| 22 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.59444656 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59368464 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.56876499 |
| 25 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.50571638 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.45973425 |
| 27 | Colorectal cancer_Homo sapiens_hsa05210 | 1.42837717 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.42646516 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.40871430 |
| 30 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.35530678 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33142231 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.32918787 |
| 33 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.29606244 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.28223071 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.25583793 |
| 36 | Prostate cancer_Homo sapiens_hsa05215 | 1.25180401 |
| 37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.24743519 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24317179 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.20664345 |
| 40 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.19425753 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.17786414 |
| 42 | Focal adhesion_Homo sapiens_hsa04510 | 1.16790058 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15164455 |
| 44 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.14765462 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14394158 |
| 46 | Cell cycle_Homo sapiens_hsa04110 | 1.13404442 |
| 47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12892861 |
| 48 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.12753475 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11345428 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.10141914 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 1.01907451 |
| 52 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99806383 |
| 53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.97488798 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.97451801 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.95698445 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93451013 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93361053 |
| 58 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93295944 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91248917 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.91206038 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90887536 |
| 62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89751225 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88953782 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87882838 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.87767009 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.87263718 |
| 67 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.87167188 |
| 68 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87093099 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86528523 |
| 70 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.85511649 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.85208139 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.85064399 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82947579 |
| 74 | Apoptosis_Homo sapiens_hsa04210 | 0.82735883 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.82001933 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81415951 |
| 77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.80678155 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.80412141 |
| 79 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79526343 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.76831993 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76774695 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76740286 |
| 83 | Long-term potentiation_Homo sapiens_hsa04720 | 0.76657388 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.75725378 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75715328 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.74558809 |
| 87 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.74349416 |
| 88 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74158962 |
| 89 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.74057970 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73756848 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71982281 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71107640 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.70315935 |
| 94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70032670 |
| 95 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69820423 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.69614224 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.66602636 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.66120490 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65878853 |
| 100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.65450535 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.65088897 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64957257 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64637386 |
| 104 | Melanogenesis_Homo sapiens_hsa04916 | 0.64368373 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63421556 |
| 106 | Melanoma_Homo sapiens_hsa05218 | 0.62693869 |
| 107 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61625178 |
| 108 | Axon guidance_Homo sapiens_hsa04360 | 0.59989548 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59620835 |
| 110 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59100529 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58217236 |
| 112 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58194677 |
| 113 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57869021 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57767812 |
| 115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.57140520 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55262386 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54452096 |
| 118 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54011276 |
| 119 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53786053 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53641339 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52900662 |
| 122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52443616 |
| 123 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.52277284 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51952955 |
| 125 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51440053 |
| 126 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50817714 |
| 127 | Bladder cancer_Homo sapiens_hsa05219 | 0.50547087 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50156798 |
| 129 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.48645527 |
| 130 | Tight junction_Homo sapiens_hsa04530 | 0.48131667 |
| 131 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47879035 |
| 132 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47569815 |
| 133 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47434409 |
| 134 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46812104 |
| 135 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46721547 |
| 136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45621775 |
| 137 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44348262 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43898118 |
| 139 | GABAergic synapse_Homo sapiens_hsa04727 | 0.43377481 |
| 140 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43173881 |
| 141 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.42848426 |
| 142 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42460878 |
| 143 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42302381 |
| 144 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42109529 |
| 145 | Gap junction_Homo sapiens_hsa04540 | 0.40422592 |
| 146 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39808797 |
| 147 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39519140 |
| 148 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39293884 |
| 149 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38961046 |
| 150 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37899324 |
| 151 | Adherens junction_Homo sapiens_hsa04520 | 0.37250354 |
| 152 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.36967242 |
| 153 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36765980 |
| 154 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.36361165 |
| 155 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35772620 |

